Neuberg Diagnostics an international alliance of 5 leading path labs from India, Sri Lanka, South Africa and UAE is set to transform the early detection of diseases in the country.
The conglomerate, which has a combined diagnostic expertise of over two centuries, is a partnership with Anand Diagnostic Laboratory, Supratech Micropath, Ehrlich Lab, Global Labs and Minerva Labs, which has already made their presence in Karnataka, Gujarat, Tamil Nadu, South Africa & UAE. These laboratories will have collective annual revenue of Rs.400 crore with the formation of the new entity.
It will have Neuberg will have 3 world class global reference laboratories located in Bengaluru, Ahmedabad, and Durban in South Africa to conduct range of testing using new generation In vitro diagnostics techniques along with total lab automation & big data analytics tools supported by robust world-class laboratory information system.
The company conceived by Dr GSK Velu who is the face behind Trivitron Healthcare known for its medical device capability. Now Dr Velu is chairman Neuberg Diagnostics where Anand K is the chief executive officer, Dr Sujay Prasad as medical director and Dr Sandip Shah as executive director. The technical board has Dr Jayaram, Dr Bhagyam Nair, Dr Lorna Madurai, and Dr Bhavini Shah among others.
The launch in Bengaluru had minister of state for health and family welfare India Anupriya Patel, Dr Rajitha Senaratne minister of health, nutrition & indigenous medicine, Sri Lanka, Dr Awatif Juma al Bahar, medical director, Dubai Health Authority, UAE, and Prof Salim S Abdool Karim, director, CAPRISA & Pro vice-chancellor, University of KwaZulu-Natal South Africa.
The consortium will pool in advanced diagnostics technology and perform 5,000 plus pathological tests, promoting prevention and early diagnosis. It will combine conventional pathology testing, new generation laboratory techniques and basic radiology & imaging techniques.
“The aim of the partnership is to develop a new shared services model for the provision of pathology services in the Middle East, Africa including west and South India. Neuberg Diagnostics is built on the vision to provide modern, innovative and sustainable services that deliver world-class lab facilities with the focus on high-end technology and services like genomics and proteomics to doctors and patients alike, said Dr Velu.
“An association with the pathology experts will lead to the implementation of best practices, adoption of new technology and convert research into innovation, benefiting the medical community and ultimately improving patient care, said Anand K, CEO, Neuberg Diagnostics.
According to minister of state for health and family welfare, Patel, a global consortium is set to be a major platform to introduce new generation pathology services to the sector, thereby increasing the quality and affordability of the country’s healthcare services.